Who We Are

Show

Sort By

David Reintjes
TPG Capital Asia
Asia

David Reintjes is General Counsel for TPG Capital Asia. Prior to joining TPG, David was a member of the corporate and securities practice groups at Sonnenschein Nath & Rosenthal LLP and Kelly, Hart & Hallman LLP. David graduated from the University of Notre Dame with a BA and received his JD from the University of Kansas School of Law.

Close

David Reintjes

TPG Capital Asia
Jeffrey Rhodes
TPG Capital
Americas

Jeffrey Rhodes is a Partner of TPG in the San Francisco office, where he co-leads the healthcare group and the firm's investment activities in the healthcare services, pharmaceutical, and medical device sectors. Jeff serves on the boards of Beaver-Visitec International, Immucor, Kelsey Seybold Clinic, Kindred at Home, Kindred Healthcare, LifeStance Health, and WellSky. He previously served on the Boards of Biomet, EnvisionRx, IMS Health, Par Pharmaceutical Companies, Surgical Care Affiliates, Zimmer Biomet and as a founding Board member of the Healthcare Private Equity Association. Jeff received his MBA from the Harvard Business School and earned his BA in economics from Williams College.

Close

Jeffrey Rhodes

TPG Capital
Kristin Richards
TPG Growth
Americas

Kristin Richards is a Director at TPG Growth based in San Francisco, where she works on TPG's human capital team. Prior to joining TPG in 2016, Kristin served as Vice President of Executive Talent for Greylock Partners. Before joining Greylock, Kristin spent close to 10 years at Spencer Stuart, where most recently she was a Consultant in their Technology, Communications & Media and Board Services practices. Prior to joining Spencer Stuart, Kristin spent four years as Director of Executive Recruiting at Accel-KKR. Kristin received her BA from the University of California, Davis.

Close

Kristin Richards

TPG Growth
John Rogers
The Rise Fund
Americas

John Rogers is a Partner with the Rise Fund and the fund's Sector Lead for Education. Most recently, John was a founding partner of Bridges Ventures’ U.S. Sustainable Growth Fund, where he helped to lead the development of Bridges’ U.S. investment strategy and led Bridges’ investment in Springboard Education. Prior to his work with Bridges, John was a Partner and Group Head for the Healthcare and Education Group at Gryphon Investors, where he led investments in Accelerated Rehabilitation, Delta Career Education, and Envision. Before joining Gryphon, John was a Vice President at DB Capital Partners, Deutsche Bank’s principal investment arm, where he was an early investor in Sylvan Learning Centers, Strayer University, Concentra Health and Fresenius Medical Care. John began his career in the public and nonprofit sectors, leading the development of innovative economic development and public health programs for the City of Oakland and the Alameda County Health Care Services Agency. He holds a BA in political science from Yale University and an MBA from Stanford University. John recently completed a Doctorate in Education at the University of Pennsylvania, where his research focused on quantifying the impact of internship participation on the wages of community college graduates.  

Close

John Rogers

The Rise Fund
Robert Roley
TPG Capital

Robert Roley is a Director of Portfolio Operations for Software and Enterprise Technology with TPG Capital.  Prior to joining TPG in 2020, he was responsible for multiple software business units of SS&C Technologies. Robert joined SS&C in 2015 through its acquisition of former TPG portfolio company Advent Software, where he began in 2001 and held leadership roles across product strategy, sales, professional services and client success before leading the business. Robert has a bachelor's degree in Operations and Management Information Systems from Santa Clara University and is an active member of the Young Presidents Organization (YPO).

Close

Robert Roley

TPG Capital
Maggie Romero
Client and Capital Formation
Americas

Maggie Romero is a Principal with TPG's Client and Capital Formation group. Prior to joining TPG in 2017, Maggie worked as a Management Consultant at Bain & Company and The Bridgespan Group. Maggie received her MBA and Masters in Education from Stanford, and her BBA with highest honors from the University of Texas at Austin.

Close

Maggie Romero

Client and Capital Formation
Jason Ruckman
TPG Real Estate
Americas

Close

Jason Ruckman

TPG Real Estate
Neal Sangal
TPG Capital
Americas

Neal Sangal is a Vice President at TPG Capital based in San Francisco, and has been with TPG since 2018. He focuses on the industrials and services sectors and is actively involved in the firm’s investment in CLEAResult. Prior to joining TPG, Neal was with Audax Private Equity. He received a BA from the University of Michigan and a JD/MBA from Stanford Law School and the Stanford Graduate School of Business.

Close

Neal Sangal

TPG Capital
Ganen Sarvananthan
TPG Capital Asia
Asia

Ganen Sarvananthan is Co-Managing Partner of TPG Capital Asia. Prior to joining TPG in 2014, Ganen served as Head of Investments at Khazanah Nasional Berhad for almost a decade. He also worked at UBS Investment Bank based in London, Hong Kong and Singapore for more than seven years. He studied law at University College London and is a Barrister-at-Law (England and Wales).

Close

Ganen Sarvananthan

TPG Capital Asia
John Schilling
TPG Capital
Americas

John Schilling is a Partner, leads the Operations team for TPG Capital in the U.S. and E.U., and co-leads the healthcare team. Prior to joining TPG in 2011, John managed Sales and Marketing for the U.S. pharmaceutical business at Abbott and was a Partner at McKinsey & Company. John received his undergraduate degree in Biomedical Engineering from Duke, a Master’s in Biomedical Engineering from Johns Hopkins where he was a Bozzelli Scholar, and an M.D. from the University of Chicago where he received the Joseph A. Capps Award for the most outstanding student in clinical medicine. Thereafter, John conducted his residency training in surgery at Johns Hopkins. While at TPG, John has played leadership roles on TPG’s investments in Adare Pharmaceuticals, Aptalis, Beaver Visitec International, EnvisionRx, Immucor, and Par Pharmaceutical.

Close

John Schilling

TPG Capital